Suzie Tetang-Ndiang

Yaounde, CE, Cameroon

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Effect of dolutegravir-based antiretroviral therapy transition on body mass index in adolescents living with HIV: secondary analysis of data from the ANRS 12225 Pediacam III cohort in Cameroon.

Effect of dolutegravir-based antiretroviral therapy transition on body mass index in adolescents living with HIV: secondary analysis of data from the ANRS 12225 Pediacam III cohort in Cameroon.

Journal: AIDS research and therapy

Published: October 23, 2025

Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon.

Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon.

Journal: Vaccines

Published: April 07, 2025

Frequency and Factors Associated To School Delay among HIV-infected and Uninfected Children Followed in the ANRS 12,225-PEDIACAM III Cohort in Cameroon.

Frequency and Factors Associated To School Delay among HIV-infected and Uninfected Children Followed in the ANRS 12,225-PEDIACAM III Cohort in Cameroon.

Journal: AIDS and behavior

Published: March 19, 2025

Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.

Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.

Journal: HIV medicine

Published: September 24, 2020

Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon.

Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon.

Journal: PloS one

Published: September 07, 2020

A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis.

A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis.

Journal: Pediatrics

Published: June 03, 2019

Early treated HIV-infected children remain at risk of growth retardation during the first five years of life: Results from the ANRS-PEDIACAM cohort in Cameroon.

Early treated HIV-infected children remain at risk of growth retardation during the first five years of life: Results from the ANRS-PEDIACAM cohort in Cameroon.

Journal: PloS one

Published: November 13, 2018

Virologic Response to Early Antiretroviral Therapy in HIV-infected Infants: Evaluation After 2 Years of Treatment in the Pediacam Study, Cameroon.

Virologic Response to Early Antiretroviral Therapy in HIV-infected Infants: Evaluation After 2 Years of Treatment in the Pediacam Study, Cameroon.

Journal: The Pediatric infectious disease journal

Published: August 26, 2017

Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.

Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.

Journal: The lancet. HIV

Published: April 21, 2017

Feasibility of Routinely Offering Early Combined Antiretroviral Therapy to HIV-infected Infants in a Resource-limited Country: The ANRS-PediaCAM Study in Cameroon.

Feasibility of Routinely Offering Early Combined Antiretroviral Therapy to HIV-infected Infants in a Resource-limited Country: The ANRS-PediaCAM Study in Cameroon.

Journal: The Pediatric infectious disease journal

Published: June 30, 2015

Different factors associated with loss to follow-up of infants born to HIV-infected or uninfected mothers: observations from the ANRS 12140-PEDIACAM study in Cameroon.

Different factors associated with loss to follow-up of infants born to HIV-infected or uninfected mothers: observations from the ANRS 12140-PEDIACAM study in Cameroon.

Journal: BMC public health

Published: October 11, 2014

Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?

Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?

Journal: BMC pediatrics

Published: September 10, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026